Abstract:Chaojun Tang, Yalan Li, Yong Lai Department of Anesthesiology, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, People's Republic of China Correspondence: Chaojun Tang, Department of Anesthesiology, The First Affiliated Hospital of Jinan University. 613 West Huangpu Avenue, Guangzhou, 510630, Guangdong Province, People's Republic of China, Tel +86-751-6926690, Email Yalan Li, Department of Anesthesiology, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, People's Republic of China, Tel +86-751-6926690, Email Purpose: This study aims to investigate whether dexmedetomidine could prevent postoperative cognitive dysfunction and delirium in patients with lobectomy. Patients and Methods: Patients with lung cancer who underwent thoracoscopic lobectomy under general anesthesia were enrolled in this study and divided into dexmedetomidine group or control group. Propensity-score match (PSM) was used to reduce the bias and imbalance of confounding variables. After PSM, 87 patients in each group were included. Primary outcomes were postoperative cognitive function and delirium. Secondary outcomes include plasma TNF-α, IL-6, and S100 β protein concentrations. Adverse events were also collected. Results: There were no significant differences in the demographic characteristics and hemodynamic parameters between the two groups. Compared with the control group, the MoCA scores were significantly higher ( P < 0.01), while the incidence of delirium ( P < 0.01) and the plasma TNF-α ( P < 0.01), IL-6 ( P < 0.01), and S100 β protein ( P < 0.01) concentrations were significantly lower in the dexmedetomidine group at 7 days post-operatively. The incidences of adverse events were similar between the two groups. Conclusion: Dexmedetomidine could prevent postoperative cognitive dysfunction and delirium in patients with lobectomy by decreasing neuroinflammation. Keywords: Dexmedetomidine, pneumonectomy, cognitive dysfunction, postoperative cognitive complications, inflammation Lung cancer has been the leading cause of death from cancer globally. 1 Approximately 870,982 new cases and 766,898 cancer-related deaths are estimated to occur in China in 2022. 2 Surgical resection is one of the main therapies for lung cancer, and pulmonary lobectomy is considered the preferred treatment with the best curative effects and prolonged survival. 3,4 Postoperative cognitive dysfunction (POCD) and delirium are common conditions after surgery, expressed as a decline in cognitive function, memory, and orientation. 5 The incidence of POCD and delirium after thoracic surgery including pulmonary lobectomy has been estimated at 31.9% and 18.8%, respectively. 6 Delirium is a harbinger of POCD, usually occurs within the first 3 postoperative days; while POCD occurs at the end of the first week and has no effect on consciousness, and its duration may be significantly prolonged. 7 Currently, the pathogenesis of POCD and delirium is still unclear, some studies argued that surgery and/or anesthesia caused systemic inflammatory response may be a reason. 8,9 Thus, it is important to select appropriate narcotic drugs to effectively control inflammation after pulmonary lobectomy and prevent the occurrence of POCD and delirium, especially in the elderly who are vulnerable to memory disturbances. Dexmedetomidine is an α2-adrenoceptor agonist with sedative, anxiolytic, sympatholytic, and analgesic-sparing effects, and minimal depression of respiratory function. 10 Its use has been linked to reductions in postoperative delirium, stress, and inflammatory responses, resulting in improved nervous system protection. 11 Recent findings by Glumac et al showed that preoperative administration of corticosteroids ameliorates inflammatory response induced by surgery and thereby decreased the risk of early POCD after cardiac surgery. 12 Moreover, some other studies reported that the incidence of POCD and delirium caused by anesthesia was reduced in patients treated with dexamethasone. 13,14 However, the effect of dexmedetomidine on cognitive function and delirium was rarely reported in lung cancer patients with lobectomy. This study aims to evaluate whether dexmedetomidine could provide protection from inflammation in the central nervous system (CNS) and assess its effect on the risk of cognitive function and delirium in elderly patients with lobectomy. We hypothesized that cognitive dysfunction and incidence of delirium would be reduced in patients who received dexmedetomidine compared with those in the control group. From January 2019 to Dec. 2021, medical records of patients aged 65 years or -Abstract Truncated-

[Effects of dexmedetomidine on injury of lungs and CHOP protein expression in elderly patients with lung cancer during one-lung ventilation]

Effect Of Dexmedetomidine On Perioperative Inflammation And Lung Protection In Elderly Patients Undergoing Radical Resection Of Lung Cancer

Effects of dexmedetomidine on perioperative myocardial injury in elderly patients with single lung ventilation

Dexmedetomidine improves lung injury after one-lung ventilation in esophageal cancer patients by inhibiting inflammatory response and oxidative stress

Effect of Different Doses of Dexmedetomidine on Lung Injury During Laparoscopic Gallbladder Surgery in Elderly Patients with Mild Obstructive Ventilation Dysfunction

The pulmonary protection of dexmedetomidine in combination with parecoxib in patients undergoing thoracotomy during one-lung ventilation

[Dexmedetomidine improves function of lung oxygenation in patients with moderate chronic obstructive pulmonary disease underwent lung cancer surgery].

Intraoperative Dexmedetomidine for Prevention of Postoperative Cognitive Dysfunction and Delirium in Elderly Patients with Lobectomy: A Propensity Score-Matched, Retrospective Study

Dexmedetomidine attenuates inflammatory response and chronic pain following video-assisted thoracoscopic surgery for lung cancer

Prevention of dexmedetomidine on postoperative delirium and early postoperative cognitive dysfunction in elderly patients undergoing hepatic lobectomy.

Dexmedetomidine Attenuates Inflammation in Elderly Patients Following Major Hepatobiliary and Pancreatic Surgery: A Randomized Clinical Trial

Effect of Dexmedetomidine or Epidural Blockade Combined with General Anesthesia on Perioperative Inflammatory Cytokines in Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery

Effect of dexmedetomidine on the Montreal Cognitive Assessment in older patients undergoing pulmonary surgery

Effects of Dexmedetomidine on Cardioprotection and Other Postoperative Complications in Elderly Patients after Cardiac and Non-Cardiac Surgerie

Effects of Dexmedetomidine on the Emergency Agitation and Inflammatory Cytokines During Resuscitation Period in Patients Undergoing Thoracic Surgery under General Anesthesia

Efficacy of Different Doses of Dexmedetomidine for Prevention of Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy

Application Effect of Dexmedetomidine and Dezocine in Patients Undergoing Lung Cancer Surgery under General Anesthesia and Analysis of Their Roles in Recovery Time and Cognitive Function

Effect of dexmedetomidine in early postoperative cognitive dysfunction in elderly patients after gastrointestinal surgery

Effect of dexmedetomidine on postoperative nausea and vomiting in female patients undergoing radical thoracoscopic lung cancer resection

Effect of Dexmedetomidine on Postoperative Plasma Neurofilament Light Chain in Elderly Patients Undergoing Thoracoscopic Surgery: A Prospective, Randomized Controlled Trial

Influencing Factors of Dexmedetomidine on Postoperative Myocardial Protection in Patients with Video-Assisted Thoracoscopic Surgery Lobectomy: A Retrospective Cohort Study.